NCT02988284

Brief Summary

Three hundred healthy individuals will be participants of the study. Participants will evaluate with the following assessment tools: Demographic datas; age, gender, height, body mass, will be recorded. Gait parameters (step length, variation of step length) will evaluate with Gait trainer Biodex 2, at participant's preferred speed.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2017

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2016

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 9, 2016

Completed
23 days until next milestone

Study Start

First participant enrolled

January 1, 2017

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

December 9, 2016

Status Verified

December 1, 2016

Enrollment Period

1 month

First QC Date

December 7, 2016

Last Update Submit

December 8, 2016

Conditions

Keywords

Gait variability

Outcome Measures

Primary Outcomes (1)

  • Step length variability assesment while walking.

    Initially evaluation at first minute

Interventions

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

Healthy individuals

You may qualify if:

  • Want to participate

You may not qualify if:

  • Have passive joint limitation at extremities Surgery at last 5 year Systemic problems such as neurologic disorders, rheumatoid disorders… Another orthopedic anomalies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Assistant, PhD, PT

Study Record Dates

First Submitted

December 7, 2016

First Posted

December 9, 2016

Study Start

January 1, 2017

Primary Completion

February 1, 2017

Study Completion

February 1, 2017

Last Updated

December 9, 2016

Record last verified: 2016-12